In three BC cell lines, downregulation of ANXA9 protein levels decreased phosphorylation of AKT, mTOR expression, and STAT3 phosphorylation, whereas the total protein level of AKT and STAT3 was not affected (Fig. 6G). The gene discussed is AKT1; the disease is breast cancer.